Advertisement

Topics

Owlstone Medical to Provide Breath Biomarker Services for 4D Pharma Using Breath Biopsy Platform

05:00 EST 7 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Partnership aims to identify non-invasive VOC biomarkers in development of live biotherapeutics for disease diagnosis and patient stratification Owlstone Medical, a diagnostics company developing a breathalyzer for di...

Other Sources for this Article

Zyme Communications
Sarah Jeffery, +44 (0)7771 730 919
sarah.jeffery@zymecommunications.com

NEXT ARTICLE

More From BioPortfolio on "Owlstone Medical to Provide Breath Biomarker Services for 4D Pharma Using Breath Biopsy Platform"

Advertisement
Quick Search
Advertisement
Advertisement